Fulton Breakefield Broenniman LLC raised its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 19.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,569 shares of the company's stock after purchasing an additional 1,867 shares during the period. Fulton Breakefield Broenniman LLC's holdings in Procter & Gamble were worth $1,843,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble in the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble in the 1st quarter valued at about $33,000. Mizuho Securities Co. Ltd. increased its stake in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. This represents a 4.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company's stock, valued at approximately $48,703,248.36. The trade was a 3.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 in the last quarter. 0.20% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of research firms recently issued reports on PG. UBS Group lowered their target price on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research note on Wednesday, September 17th. Barclays lowered their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 1st. Bank of America lowered their target price on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research note on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $172.58.
View Our Latest Analysis on PG
Procter & Gamble Trading Down 1.2%
NYSE PG opened at $150.67 on Thursday. The company has a market cap of $352.64 billion, a PE ratio of 23.14, a PEG ratio of 4.05 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The stock has a 50 day moving average of $155.26 and a 200-day moving average of $159.72.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.